This morning, GlaxoSmithKline announced a new initiative to help prevent mother-to-child transmission of HIV and to support orphans and vulnerable children. Called the “Positive Action for Children” fund, it’s been created with $80 million to be made available over 10 years.
In addition to this, the fund will also include “£10 million seed funding to support a Public Private Partnership into research and development of new HIV/AIDS medicines for children.”
You can read more about the Fund here.
-Chris Scott
The ONE Blog is a daily log of the anti-poverty movement. The site is operated by ONE staff, with frequent contributions from volunteers, members and partner organizations.
The ONE Blog updates readers daily with the latest in global development news and analysis and what ONE members and our partners are doing around the world to influence world leaders in the fight against global poverty.
The content of each post and each comment represents the views of that author and does not necessarily reflect the views of ONE or ONE Action. ONE does not support or oppose any candidate for elected office, and any post expressing support or opposition for a candidate is not endorsed by ONE.
July 14, 2009 at 10:23 am
Thank you to GSK for taking action and continuing to show leadership and thank you to the ONE Campaign for highlighting the new initiative.
For related reading, the U.S. Chamber BCLC published a piece about GSK’s Positive Action program http://www.uschamber.com/bclc/profiles/globalcitizen_gsk.htm, as well as pieces on the company’s other work in developing and underdeveloped countries http://www.uschamber.com/bclc/companies/glaxosmithkline.htm.